Insulin Requirement | List of Frontiers open access articles

Original Research

Published on 19 Apr 2022

Insulin Requirement and Complications Associated With Serum C-Peptide Decline in Patients With Type 1 Diabetes Mellitus During 15 Years After Diagnosis

in Pediatric Endocrinology

Junghwan Suh
Hae In Lee
Myeongseob Lee
Kyungchul Song
Han Saem Choi
Ahreum Kwon
Ho-Seong Kim
Hyun Wook Chae

Frontiers in Endocrinology

doi 10.3389/fendo.2022.869204

7,836 views
11 citations

Original Research

Published on 26 Jun 2025

Real-world evaluation of safety and efficacy of AHCL systems in young children with type 1 diabetes: a 1-year assessment

in Clinical Diabetes

Daniele Franzone
Giordano Spacco
Andrea Piano
Giulia Siri
Giacomo Tantari
Giuseppe d’Annunzio
Maria Grazia Calevo
Mohamad Maghnie
Nicola Minuto
Marta Bassi

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1590964

2,912 views

Case Report

Published on 28 Feb 2022

Efficacy of Dulaglutide in a Patient With Type 2 Diabetes, High Cardiovascular Risk, and HIV: A Case Report

in Clinical Diabetes

Angela Dardano
Michele Aragona
Giuseppe Daniele
Roberto Miccoli
Stefano Del Prato

Frontiers in Endocrinology

doi 10.3389/fendo.2022.847778

5,683 views
4 citations

Original Research

Published on 24 Aug 2022

Immunological balance between Treg and Th17 lymphocytes as a key element of type 1 diabetes progression in children

in T Cell Biology

Aleksandra Starosz
Milena Jamiołkowska-Sztabkowska
Barbara Głowińska-Olszewska
Marcin Moniuszko
Artur Bossowski
Kamil Grubczak

Frontiers in Immunology

doi 10.3389/fimmu.2022.958430

7,271 views
33 citations

Original Research

Published on 28 Apr 2022

Short-Term Effectiveness and Reduction in Insulin Requirements in Patients With Type 2 Diabetes Treated With IdegLira in a Real-World Setting

in Clinical Diabetes

Alex Ramírez-Rincón
Carlos E. Builes-Montaño
Jaime A. Hincapié-García
Victor M. Blanco
José F. Botero-Arango

Frontiers in Endocrinology

doi 10.3389/fendo.2022.828607

3,887 views
8 citations

Original Research

Accepted on 17 Feb 2026

Predictive Value of OGTT Parameters and Clinical Markers in Gestational Diabetes Mellitus: A Prospective Randomized Controlled Trial from a Tertiary Center in Türkiye

in Developmental Endocrinology

Batuhan Turgay
Uğurcan Zorlu
Harun Kılıçkıran
Kayra Turgay
Gülşah Aynaoğlu
A.Seval Ozgu-Erdinc

Frontiers in Endocrinology

Brief Research Report

Published on 30 Nov 2023

Modern glucose-lowering drugs in liver transplant recipients: improvement in weight, glycemic control, and potentially allograft steatosis

in Abdominal Transplantation

Srilakshmi Atthota
Kayla Joyal
Mariesa Cote
Riley Scalzo
Ruby Singh
Nikita Consul
Aoife Kilcoyne
Emily D. Bethea
Leigh Anne Dageforde

Frontiers in Transplantation

doi 10.3389/frtra.2023.1223169

5,076 views
12 citations

Original Research

Published on 09 Oct 2020

Glutamic Acid Decarboxylase Injection Into Lymph Nodes: Beta Cell Function and Immune Responses in Recent Onset Type 1 Diabetes Patients

in Autoimmune and Autoinflammatory Disorders

Rosaura Casas
Fabrícia Dietrich
Hugo Barcenilla
Beatriz Tavira
Jeanette Wahlberg
Peter Achenbach
Johnny Ludvigsson

Frontiers in Immunology

doi 10.3389/fimmu.2020.564921

7,285 views
33 citations

Case Report

Published on 03 Jun 2025

Case Report: Usefulness, effectiveness, and safety of an advanced hybrid closed-loop system in a child with early identification of type 1 diabetes

in Clinical Diabetes

Chiara Mameli
Maddalena Macedoni
Francesca Redaelli
Agnese Petitti
Adelina Hajro
Alessandra Bosetti
Gianvincenzo Zuccotti

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1598264

2,204 views

Case Report

Published on 16 Jun 2025

Case Report: long-term misdiagnosis and follow-up of a patient with HNF4A-MODY carrying a new de novo mutation

in Clinical Diabetes

Jing Luo
Ai Li
Xiaoli Wang

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1509135

2,622 views

Systematic Review

Published on 10 May 2024

Meta-analysis shows that mesenchymal stem cell therapy can be a possible treatment for diabetes

in Clinical Diabetes

Umm E. Habiba
Nasar Khan
David Lawrence Greene
Khalil Ahmad
Sabiha Shamim
Amna Umer

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1380443

18,191 views
24 citations

Systematic Review

Published on 09 Feb 2026

Clinical parameters and emerging biomarkers of partial remission in pediatric type 1 diabetes: a systematic review

in Diabetes: Molecular Mechanisms

Camille Dikranian
Oumayma Hadara
Philippe A. Lysy

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1758848

941 views

Original Research

Published on 20 Jun 2024

Efficacy of advanced hybrid closed loop systems in cystic fibrosis related diabetes: a pilot study

in Clinical Diabetes

Marta Bassi
Daniele Franzone
Francesca Dufour
Giordano Spacco
Federico Cresta
Giuseppe d’Annunzio
Giacomo Tantari
Maria Grazia Calevo
Carlo Castellani
Nicola Minuto

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1347141

3,067 views
4 citations

Clinical Trial

Published on 02 Jun 2020

Allogenic Adipose Tissue-Derived Stromal/Stem Cells and Vitamin D Supplementation in Patients With Recent-Onset Type 1 Diabetes Mellitus: A 3-Month Follow-Up Pilot Study

in Autoimmune and Autoinflammatory Disorders

Debora B. Araujo
Joana R. Dantas
Karina R. Silva
Débora L. Souto
Maria de Fátima C. Pereira
Jessica P. Moreira
Ronir R. Luiz
Cesar S. Claudio-Da-Silva
Monica A. L. Gabbay
Sergio A. Dib

Frontiers in Immunology

doi 10.3389/fimmu.2020.00993

10,279 views
45 citations

Original Research

Published on 14 Sep 2023

Body mass index and partial remission in 119 children with type 1 diabetes—a 6-year observational study

in Pediatric Endocrinology

Magdalena Sokołowska-Gadoux
Przemysława Jarosz-Chobot
Joanna Polanska
Alicja Kalemba
Agata Chobot

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1257758

3,195 views
2 citations

Original Research

Published on 20 Jun 2023

Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders

in Clinical Diabetes

Valeria Sordi
Paolo Monti
Vito Lampasona
Raffaella Melzi
Silvia Pellegrini
Bart Keymeulen
Pieter Gillard
Thomas Linn
Emanuele Bosi
Ludger Rose

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1175640

4,448 views
6 citations

Articles

Insulin Requirement and Complications Associated With Serum C-Peptide Decline in Patients With Type 1 Diabetes Mellitus During 15 Years After Diagnosis

Real-world evaluation of safety and efficacy of AHCL systems in young children with type 1 diabetes: a 1-year assessment

Efficacy of Dulaglutide in a Patient With Type 2 Diabetes, High Cardiovascular Risk, and HIV: A Case Report

Immunological balance between Treg and Th17 lymphocytes as a key element of type 1 diabetes progression in children

Short-Term Effectiveness and Reduction in Insulin Requirements in Patients With Type 2 Diabetes Treated With IdegLira in a Real-World Setting

Predictive Value of OGTT Parameters and Clinical Markers in Gestational Diabetes Mellitus: A Prospective Randomized Controlled Trial from a Tertiary Center in Türkiye

Modern glucose-lowering drugs in liver transplant recipients: improvement in weight, glycemic control, and potentially allograft steatosis

Glutamic Acid Decarboxylase Injection Into Lymph Nodes: Beta Cell Function and Immune Responses in Recent Onset Type 1 Diabetes Patients

Case Report: Usefulness, effectiveness, and safety of an advanced hybrid closed-loop system in a child with early identification of type 1 diabetes

Case Report: long-term misdiagnosis and follow-up of a patient with HNF4A-MODY carrying a new de novo mutation

Meta-analysis shows that mesenchymal stem cell therapy can be a possible treatment for diabetes

Clinical parameters and emerging biomarkers of partial remission in pediatric type 1 diabetes: a systematic review

Efficacy of advanced hybrid closed loop systems in cystic fibrosis related diabetes: a pilot study

Allogenic Adipose Tissue-Derived Stromal/Stem Cells and Vitamin D Supplementation in Patients With Recent-Onset Type 1 Diabetes Mellitus: A 3-Month Follow-Up Pilot Study

Body mass index and partial remission in 119 children with type 1 diabetes—a 6-year observational study

Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders